A Prospective Non-interventional Real-World Study of cabozantinib in Pretreated Patients With Advanced Renal Cell Carcinoma Refractory to Vascular Endothelial Growth Factor-Targeted Therapy (CASSIOPE)
Second- or later-line cabozantinib was effective and manageable in a real-world setting and had a safety profile consistent with previous studies.
Authors
- P. Rastogi
- Pascale Dutailly
- Pierre Bigot (ORCID: https://orcid.org/0000-0002-5669-9020)
- Rocco De Vivo
- Paul Hamberg (ORCID: https://orcid.org/0000-0002-8223-0250)
- Aline Guillot (ORCID: https://orcid.org/0000-0002-1259-6089)
- Elena Verzoni (ORCID: https://orcid.org/0000-0001-9756-6112)
- Martín Lázaro-Quintela (ORCID: https://orcid.org/0000-0002-0657-4713)
- Mathieu Laramas (ORCID: https://orcid.org/0000-0002-0918-8471)
- Giuseppe Procopio (ORCID: https://orcid.org/0000-0002-2498-402X)
- Michael Rink (ORCID: https://orcid.org/0000-0001-5403-7915)
- Bryan Qvick
- Pablo Gajate (ORCID: https://orcid.org/0000-0001-5156-7080)
- Cristina Suárez (ORCID: https://orcid.org/0000-0002-0502-5528)
- Jens Bedke (ORCID: https://orcid.org/0000-0003-2778-3108)
- Umberto Basso (ORCID: https://orcid.org/0000-0002-5075-2177)
- Michael D. Staehler (ORCID: https://orcid.org/0000-0002-4574-6522)
- Philippe Barthélémy (ORCID: https://orcid.org/0009-0006-3868-186X)
- Valérie Perrot (ORCID: https://orcid.org/0000-0002-5541-728X)
- Jean‐Christophe Eymard
Institutions
- Ipsen (France) (FR)
- University Hospital Complex Of Vigo (ES)
- LMU Klinikum (DE)
- Sint Franciscus Gasthuis (NL)
- Institut de Cancérologie Strasbourg (FR)
- Galicia Sur Biomedical Foundation (ES)
- Ipsen (United Kingdom) (GB)
- Istituto Oncologico Veneto (IT)
- Centre Hospitalier Universitaire d'Angers (FR)
- St. Marien Hospital (DE)
- Instituto Ramón y Cajal de Investigación Sanitaria (ES)
- Vall d'Hebron Hospital Universitari (ES)
- Institut Jean Godinot (FR)
- Générale de Santé (FR)
- Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
- International Renal Research Institute of Vicenza (IT)
- Klinikum Stuttgart (DE)
- Hospital Universitario Ramón y Cajal (ES)
- Vall d'Hebron Institute of Oncology (ES)
- Ludwig-Maximilians-Universität München (DE)
- Université Grenoble Alpes (FR)
Publication Details
- Journal
- Clinical Genitourinary Cancer
- Published
- 2024-11-29
- DOI
- https://doi.org/10.1016/j.clgc.2024.102285
- Citations
- 1
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.42
Funders
- Ipsen